Immunogenic cell death and DAMPs in cancer therapy
By D. Krysko, Abhishek D Garg, A. Kaczmarek, O. Krysko, P. Agostinis, Peter Vandenabeele. Nature Reviews. Cancer, 2012
2,776 citations recorded by the source corpus.
Subfields: Epidemiology, Immunology, Physiology
View Paper: https://www.semanticscholar.org/paper/187e56b36d0bf1c205e42fe37daed20d49a36134
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
- Guido Kroemer
- Beth Levine
- Douglas R. Green
- L. Galluzzi
- N. Mizushima
- E. White
- D. Klionsky
- I. Slaninová
In Immunology
In Physiology
Citations in the corpus
- Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases (2017, neutral): “HMGB1 also stimulates production of pro-inflammatory cytokines, such as CXCL8 from neutrophils and macrophages and thus, accelerates ICD [343].”
- Consensus guidelines for the detection of immunogenic cell death (2014, background): “, it can involve a genetically encoded molecular machinery;(4,5,21) (3) similar to their necrotic counterparts, apoptotic cells can sometimes be detected by the immune system and elicit an adaptive immune response specific for dead cell-associated antigens.(6,7,22,23) Thus, although apoptosis as a p”
- The role of oxidative stress during inflammatory processes (2013, background): “…al., 2005), stroke (Schulze et al., 2013), circulatory shock and trauma (Andersson and Tracey, 2011), diabetes (Nogueira-Machado et al., 2011), cancer (Krysko et al., 2012), and arthritis (Harris et al., 2012), and it also acts as a key pro-inflammatory cytokine involved in the pathogenesis of…”